GlassScriptPhysician profile
Jerri Lynn Shealy
NPI 1477661031
$2,278.50
in general payments reported to CMS, 2019-2025
18 companies · $499 in 2025
The $499 reported for 2025 was more than what 93% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $226 · 2021: $258 · 2022: $226 · 2023: $307 · 2024: $481 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $381.54 | 2019-2024 | Jornay Pm |
| Corium, LLC | $305.00 | 2021-2025 | Azstarys |
| Pfizer INC. | $296.14 | 2019-2025 | |
| Glaxosmithkline, LLC. | $191.18 | 2019-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $188.09 | 2021-2024 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $182.08 | 2019-2022 | |
| Adlon Therapeutics L.P. | $144.49 | 2019-2021 | |
| Tris Pharma INC | $137.60 | 2020-2024 | Dyanavel Xr |
| Sanofi-Aventis U.S. LLC | $121.92 | 2024-2025 | |
| Alk-Abello, INC | $91.69 | 2025 | Neffy, Grastek, Odactra |
| Cranial Technologies, INC | $58.47 | 2024-2025 | Doc Band |
| Sanofi Pasteur INC. | $55.85 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $41.96 | 2021-2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Seqirus USA INC | $26.34 | 2021-2023 | Flucelvax Quadrivalent |
| Collegium Pharmaceutical, INC. | $16.63 | 2025 | Jornay Pm |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.34 | 2025 | Nexplanon |
| Verrica Pharmaceuticals INC. | $13.68 | 2025 | Ycanth |
| Vertical Pharmaceuticals, LLC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerri Shealy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.